If results remain positive, FDA approval could come as early as 20262027
Bottom line: cost matters, but safety and medical oversight have to come first
However, as a result of metal-based NP exposure, the mitochondrial electron-transport chain (METC) would be disrupted, thus resulting in the elevation of intracellular ROS level (Ashrafi Hafez et al., 2019)
Your primary care provider or endocrinologist should review your baseline TSH and free T4 levels before starting GLP-1 therapy, and periodic monitoring during treatment ensures any levothyroxine dose adjustments are made promptly
if supplementation is stopped, cellular glutathione levels gradually decline back to baseline within a month, underscoring the need for consistent, ongoing support in chronic illness management
What if the cold chain breaks during travel